FAPA and MPS to Host a Stakeholders’ Forum on SDP

Separation of Dispensing and Prescribing Practices (SDP)

February 25, 2017

Pakistan Government to Review Ammendments to the Drug Law After Tragic Protest

March 15, 2017

Published by fapa_admin at February 25, 2017

Tags

FAPA and MPS to Host a Stakeholders’ Forum on SDP this May 2017

FAPA President Mr. Joseph Wang met with MPS Officials last Feb 13 and 15, 2017 to finalize the program and venue of the upcoming forum

FAPA President Mr. Joseph Wang together with MPS Officials

FAPA President Mr. Joseph Wang visited Kuala Lumpur to meet with officials from the Malaysian Pharmaceutical Society (MPS) last February 13 and 15, 2017. The meetings were held at Hotel Istana Kuala Lumpur City Centre where the May 2017 Forum on SDP and FAPA meetings are set to be held this coming May 11-13, 2017. The celebration of the 50th Anniversary is also set to be held in the same venue from May 13-14, 2017.

An ocular inspection of the plenary and meeting rooms were conducted and the program for the upcoming events were finalized between the two hosts. The meetings will start with the FAPA Bureau meeting to be held in the afternoon of May 11.

FAPA President Mr. Joseph Wang meets with MPS officials las February 13 on hosting the Stakeholder's Forum on SDP this May 2017

FAPA President Mr. Joseph Wang together with MPS officials last February 13 in an occular visit

The MPS, which is set to celebrate their 50th anniversary invited the FAPA Bureau and Member Association Presidents to join their Congress’ opening ceremony in the morning of May 13 followed by a plenary lecture on SDP from a representative of the World Health Organization (WHO).

The Stakeholder’s Forum on SDP, with the theme “Addressing the Medication Safety Challenge in Asian Countries: Separation of Dispensing and Prescribing Practices” will be divided into two parts. The first part, “Achieving SDP: The Asian Experience” aims to share the specific steps and engagement with various stakeholders that Pharmacy Associations from countries like Japan, Korea and Taiwan has taken to successfully implement SDP in their country. This will be held in the afternoon of May 12, 2017. The second part, “Ensuring Patient Safety through Separation of Dispensing and Prescribing” aims to collect insights from Consumer Groups and other health professional organizations on the impact of SDP on patient outcomes and collaboration among the members of the healthcare team. The second part is set to be held in the afternoon of May 13, 2017.